DE68912745T2 - Herstellung von optisch aktiven 2-Oxoimidazolidin-derivaten. - Google Patents

Herstellung von optisch aktiven 2-Oxoimidazolidin-derivaten.

Info

Publication number
DE68912745T2
DE68912745T2 DE89312965T DE68912745T DE68912745T2 DE 68912745 T2 DE68912745 T2 DE 68912745T2 DE 89312965 T DE89312965 T DE 89312965T DE 68912745 T DE68912745 T DE 68912745T DE 68912745 T2 DE68912745 T2 DE 68912745T2
Authority
DE
Germany
Prior art keywords
optically active
oxoimidazolidine
production
group
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE89312965T
Other languages
English (en)
Other versions
DE68912745D1 (de
Inventor
Kimiaki Hayashi
Hitoshi Kubota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of DE68912745D1 publication Critical patent/DE68912745D1/de
Publication of DE68912745T2 publication Critical patent/DE68912745T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE89312965T 1988-12-16 1989-12-12 Herstellung von optisch aktiven 2-Oxoimidazolidin-derivaten. Expired - Lifetime DE68912745T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63318745A JPH0645603B2 (ja) 1988-12-16 1988-12-16 光学活性2‐オキソイミダゾリジン誘導体の製法

Publications (2)

Publication Number Publication Date
DE68912745D1 DE68912745D1 (de) 1994-03-10
DE68912745T2 true DE68912745T2 (de) 1994-05-11

Family

ID=18102470

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89312965T Expired - Lifetime DE68912745T2 (de) 1988-12-16 1989-12-12 Herstellung von optisch aktiven 2-Oxoimidazolidin-derivaten.

Country Status (17)

Country Link
US (1) US5013845A (de)
EP (1) EP0373881B1 (de)
JP (1) JPH0645603B2 (de)
KR (1) KR950009364B1 (de)
CN (1) CN1032308C (de)
AT (1) ATE100817T1 (de)
AU (1) AU622959B2 (de)
CA (1) CA2004606C (de)
DE (1) DE68912745T2 (de)
DK (1) DK174701B1 (de)
ES (1) ES2062044T3 (de)
FI (1) FI97133C (de)
HK (1) HK34195A (de)
HU (1) HU203730B (de)
IE (1) IE64315B1 (de)
IL (1) IL92456A0 (de)
SG (1) SG4795G (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104513292A (zh) * 2013-09-29 2015-04-15 山东新时代药业有限公司 一种雷米普利的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5788165A (en) * 1980-11-21 1982-06-01 Tanabe Seiyaku Co Ltd 2-oxoimidazolidine-4-carboxylic acid derivative and its preparation
JPS6058233B2 (ja) * 1982-05-24 1985-12-19 田辺製薬株式会社 2−オキソイミダゾリジン誘導体及びその製法
JPS6058233A (ja) * 1983-08-11 1985-04-04 ザ・アプジヨン・カンパニー 滅菌懸濁液及び溶液の保持及び混合装置

Also Published As

Publication number Publication date
HU203730B (en) 1991-09-30
KR900009603A (ko) 1990-07-05
AU622959B2 (en) 1992-04-30
CA2004606A1 (en) 1990-06-16
FI97133B (fi) 1996-07-15
JPH0645603B2 (ja) 1994-06-15
HK34195A (en) 1995-03-17
ES2062044T3 (es) 1994-12-16
IL92456A0 (en) 1990-08-31
CN1032308C (zh) 1996-07-17
ATE100817T1 (de) 1994-02-15
CA2004606C (en) 1997-01-07
EP0373881B1 (de) 1994-01-26
SG4795G (en) 1995-06-16
AU4619589A (en) 1990-06-21
DK638289A (da) 1990-06-17
DK638289D0 (da) 1989-12-15
EP0373881A2 (de) 1990-06-20
HU896640D0 (en) 1990-02-28
IE894004L (en) 1990-06-16
CN1043705A (zh) 1990-07-11
DK174701B1 (da) 2003-09-29
DE68912745D1 (de) 1994-03-10
IE64315B1 (en) 1995-07-26
HUT52064A (en) 1990-06-28
KR950009364B1 (ko) 1995-08-21
US5013845A (en) 1991-05-07
FI97133C (fi) 1996-10-25
EP0373881A3 (en) 1990-08-16
JPH02164869A (ja) 1990-06-25
FI895795A0 (fi) 1989-12-04

Similar Documents

Publication Publication Date Title
DK543787D0 (da) Antibakterielle midler
ATE26212T1 (de) Verwendung von amino-phenylessigs ure-derivaten zur herstellung eines immunomodulatoren arzneimittels.
DE3864707D1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
DE68912745T2 (de) Herstellung von optisch aktiven 2-Oxoimidazolidin-derivaten.
IT1237529B (it) Composti spiro-indolino-ossazine con caratteristiche fotocromatiche e fotosensibilizzatrici e procedimento per la loro preparazione
ATE111888T1 (de) Verfahren zur herstellung von optisch aktiver aminosäure.
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
AU3733489A (en) New leukotriene-b4-derivates, process for producing the same and their use as medicaments
ATE75739T1 (de) Verfahren zur herstellung von dibenzothiepinderivaten.
DK424888A (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
ATE56432T1 (de) Substituierte 1,3,4,9-tetrahydropyrano(3,4b>indole-1-essigs|ure.
ATE104975T1 (de) Verfahren zur herstellung von imidazol-derivaten.
ATE135693T1 (de) Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung
ES488385A0 (es) Procedimiento de preparacion de derivados de la xantona

Legal Events

Date Code Title Description
8364 No opposition during term of opposition